Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
Reshma L Mahtani, Charles L Vogel Sylvester Comprehensive Cancer Center, University of Miami Health System, Deerfield Beach, FL, USA Abstract: Combination therapy with a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor and an aromatase inhibitor (AI) for first-line treatment of postmenopausal wom...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019-01-01
|
| coleção: | Cancer Management and Research |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/addressing-physician-barriers-to-administering-cyclin-dependent-kinase-peer-reviewed-article-CMAR |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|